Sign in
4

Changes in Ownership

Stoke Therapeutics, Inc. Filed Acc 0001567619-19-018220

Options or other derivatives

  • Director acquired 14,777 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Krainer Adrian R. · Director

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2019-09-10 Grant or award : show line 1 in the form Director Stock Option (Right to Buy) +14,777 $28.80 2029-09-09 14,777 14,777 D
Loading xslF345X03/doc1.xml…